
The head of Roche Holding AG warned that a widespread vaccine this year is unlikely, adding to a chorus of caution from industry leaders. The first trials to deliberately infect people to accelerate development of shots could occur in the U.K. next year, while China defended giving people jabs still in clinical trials.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push